$MDGL News Article - Madrigal Pharmaceuticals to Present Additional Analyses of Data from The Phase 2 NASH Study with MGL-3196 (resmetirom) at The International Liver Congress(TM) 2019 https://marketwirenews.com/news-releases/madr...61760.html
(0)
(0)
Madrigal Pharmaceuticals Inc. (MDGL) Stock Research Links